Emerging Ceftriaxone Resistance in Paediatric <scp> <i>Shigella sonnei</i> </scp> : A 10‐Year Retrospective Study
Ceftriaxone-resistant Shigella sonnei has risen sharply in Israel since 2022, mirroring global trends. This highlights the urgent need for strengthened antimicrobial resistance surveillance and to update current guidelines for the empiric treatment of childhood shigellosis.
Authors
- Antoni Skripai (ORCID: https://orcid.org/0009-0009-8581-3142)
- Jonathan Lellouche (ORCID: https://orcid.org/0000-0002-0564-4409)
- A. Katz
- Ori Trabelsi
Institutions
- Hebrew University of Jerusalem (IL)
- Laniado Hospital (IL)
- Ariel University (IL)
Publication Details
- Journal
- Acta Paediatrica
- Published
- 2026-01-19
- DOI
- https://doi.org/10.1111/apa.70449
- Primary Topic
- Escherichia coli research studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00